Login
$MRAI
$3.03 +$0.40 (15.32%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of $86 and $21 as of June 30, 2026, and December 31, 2025, respectively
Unbilled receivables
Due from buyer for sale of business unit
Nonrelated Party
Related Party
Total due from buyer for sale of business unit
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Capitalized software, net
Operating lease right-of-use assets
Goodwill
Intangible assets, net
Security deposits
Other long-term assets
Total assets
Current liabilities:
Accounts payable
Accrued expenses
Accrued fiduciary obligations
Deferred revenue
Deferred revenue (including related party amounts of $317 and $0, respectively)
Current portion of operating lease liabilities
Current portion of convertible debentures, net
Other short-term liabilities
Vendor financing advance
Due to related party
Nonrelated Party
Related Party
Total due to related party
Total current liabilities
Other long-term liabilities
Convertible debentures, net of current portion
Operating lease liabilities, net of current portion
Deferred tax liabilities
Total liabilities
STOCKHOLDERS’ DEFICIT
Common stock, $0.0001 par value, 227,791,050 shares authorized; 26,667,334 and 24,035,610 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Additional paid-in capital
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support